İpamorelin at a glance
| Detail | What the sources say |
|---|---|
| What it is | Synthetic 5-amino-acid growth hormone secretagogue acting on the ghrelin receptor |
| Furthest stage | Phase 2 (post-operative ileus); no significant difference from placebo |
| Approved medicine? | No |
| FDA compounding list | Category 2 under the 503B interim policy since September 2023 |
From the sources to the app
| What the sources say | What PepLabo does with it |
|---|---|
| No approved label exists [1]. | PepLabo pre-fills nothing: the calculator has no default amount, and the use period after mixing stays empty until you enter it. |
| The FDA lists ipamorelin acetate among bulk substances that may present significant safety risks in compounding [3]. | Check-ins record symptoms with a severity and can be linked to a dose from the previous 72 hours; an export or a PDF report (Pro) helps you show them to a clinician. |
| Its phase 2 trial for bowel recovery after surgery is registered on ClinicalTrials.gov [2]. | The library entry lists the status with sources and dates, so you can see what has changed. |
What PepLabo does and does not do
| PepLabo does | PepLabo does not |
|---|---|
| Record each dose with the date, time and amount you enter, and the site for injections | Suggest a dose, a schedule change or a medicine |
| Remind you 15 minutes before, at the dose time, and 30 minutes after a missed dose | Tell you what to do after a missed dose; the leaflet and your prescriber do |
| Put check-ins, weight and doses on one timeline | Interpret symptoms or judge progress |
| Keep your records on your phone, with no account needed to track | Use analytics, advertising or tracking SDKs, or write to Apple Health |
| Create a PDF of your dose log for your clinician (Pro) | Replace your clinician or pharmacist |
